世界の遺伝子治療医薬品（GTMP）市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Gene Therapy Medicinal Products (GTMP) Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A14987 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、83ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、遺伝子治療医薬品（GTMP）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子治療医薬品（GTMP）の種類別市場規模（経口、注射）、用途別市場規模（がん、単発性、感染症、心血管疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝子治療医薬品（GTMP）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bluebird Bio、Sangamo、Spark Therapeutics、Dimension Therapeutics、Avalanche Bio、Celladon、Vical Inc.、Advantagene ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、注射 ・用途別分析2016年-2026年：がん、単発性、感染症、心血管疾患、その他 ・遺伝子治療医薬品（GTMP）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝子治療医薬品（GTMP）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝子治療医薬品（GTMP）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝子治療医薬品（GTMP）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝子治療医薬品（GTMP）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Gene Therapy Medicinal Products (GTMP) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Gene Therapy Medicinal Products (GTMP) size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Gene Therapy Medicinal Products (GTMP) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Gene Therapy Medicinal Products (GTMP) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Oral
Injection

Market segment by Application, can be divided into
Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other

Market segment by players, this report covers
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Gene Therapy Medicinal Products (GTMP) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gene Therapy Medicinal Products (GTMP), with revenue, gross margin and global market share of Gene Therapy Medicinal Products (GTMP) from 2019 to 2021.
Chapter 3, the Gene Therapy Medicinal Products (GTMP) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Gene Therapy Medicinal Products (GTMP) market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Gene Therapy Medicinal Products (GTMP) research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Gene Therapy Medicinal Products (GTMP)
1.2 Classification of Gene Therapy Medicinal Products (GTMP) by Type
1.2.1 Overview: Global Gene Therapy Medicinal Products (GTMP) Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type in 2020
1.2.3 Oral
1.2.4 Injection
1.3 Global Gene Therapy Medicinal Products (GTMP) Market by Application
1.3.1 Overview: Global Gene Therapy Medicinal Products (GTMP) Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cancer
1.3.3 Monogenic
1.3.4 Infectious Disease
1.3.5 Cardiovascular Disease
1.3.6 Other
1.4 Global Gene Therapy Medicinal Products (GTMP) Market Size & Forecast
1.5 Global Gene Therapy Medicinal Products (GTMP) Market Size and Forecast by Region
1.5.1 Global Gene Therapy Medicinal Products (GTMP) Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Gene Therapy Medicinal Products (GTMP) Market Size by Region, (2016-2021)
1.5.3 North America Gene Therapy Medicinal Products (GTMP) Market Size and Prospect (2016-2026)
1.5.4 Europe Gene Therapy Medicinal Products (GTMP) Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size and Prospect (2016-2026)
1.5.6 South America Gene Therapy Medicinal Products (GTMP) Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Gene Therapy Medicinal Products (GTMP) Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gene Therapy Medicinal Products (GTMP) Market Drivers
1.6.2 Gene Therapy Medicinal Products (GTMP) Market Restraints
1.6.3 Gene Therapy Medicinal Products (GTMP) Trends Analysis
2 Company Profiles
2.1 Bluebird Bio
2.1.1 Bluebird Bio Details
2.1.2 Bluebird Bio Major Business
2.1.3 Bluebird Bio Gene Therapy Medicinal Products (GTMP) Product and Solutions
2.1.4 Bluebird Bio Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bluebird Bio Recent Developments and Future Plans
2.2 Sangamo
2.2.1 Sangamo Details
2.2.2 Sangamo Major Business
2.2.3 Sangamo Gene Therapy Medicinal Products (GTMP) Product and Solutions
2.2.4 Sangamo Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Sangamo Recent Developments and Future Plans
2.3 Spark Therapeutics
2.3.1 Spark Therapeutics Details
2.3.2 Spark Therapeutics Major Business
2.3.3 Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Product and Solutions
2.3.4 Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Spark Therapeutics Recent Developments and Future Plans
2.4 Dimension Therapeutics
2.4.1 Dimension Therapeutics Details
2.4.2 Dimension Therapeutics Major Business
2.4.3 Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Product and Solutions
2.4.4 Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Dimension Therapeutics Recent Developments and Future Plans
2.5 Avalanche Bio
2.5.1 Avalanche Bio Details
2.5.2 Avalanche Bio Major Business
2.5.3 Avalanche Bio Gene Therapy Medicinal Products (GTMP) Product and Solutions
2.5.4 Avalanche Bio Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Avalanche Bio Recent Developments and Future Plans
2.6 Celladon
2.6.1 Celladon Details
2.6.2 Celladon Major Business
2.6.3 Celladon Gene Therapy Medicinal Products (GTMP) Product and Solutions
2.6.4 Celladon Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Celladon Recent Developments and Future Plans
2.7 Vical Inc.
2.7.1 Vical Inc. Details
2.7.2 Vical Inc. Major Business
2.7.3 Vical Inc. Gene Therapy Medicinal Products (GTMP) Product and Solutions
2.7.4 Vical Inc. Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Vical Inc. Recent Developments and Future Plans
2.8 Advantagene
2.8.1 Advantagene Details
2.8.2 Advantagene Major Business
2.8.3 Advantagene Gene Therapy Medicinal Products (GTMP) Product and Solutions
2.8.4 Advantagene Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Advantagene Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gene Therapy Medicinal Products (GTMP) Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Gene Therapy Medicinal Products (GTMP) Players Market Share
3.2.2 Top 10 Gene Therapy Medicinal Products (GTMP) Players Market Share
3.2.3 Market Competition Trend
3.3 Gene Therapy Medicinal Products (GTMP) Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gene Therapy Medicinal Products (GTMP) Revenue and Market Share by Type (2016-2021)
4.2 Global Gene Therapy Medicinal Products (GTMP) Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Application (2016-2021)
5.2 Gene Therapy Medicinal Products (GTMP) Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Gene Therapy Medicinal Products (GTMP) Revenue by Type (2016-2026)
6.2 North America Gene Therapy Medicinal Products (GTMP) Revenue by Application (2016-2026)
6.3 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country
6.3.1 North America Gene Therapy Medicinal Products (GTMP) Revenue by Country (2016-2026)
6.3.2 United States Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
6.3.3 Canada Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
6.3.4 Mexico Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Gene Therapy Medicinal Products (GTMP) Revenue by Type (2016-2026)
7.2 Europe Gene Therapy Medicinal Products (GTMP) Revenue by Application (2016-2026)
7.3 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country
7.3.1 Europe Gene Therapy Medicinal Products (GTMP) Revenue by Country (2016-2026)
7.3.2 Germany Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
7.3.3 France Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
7.3.5 Russia Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
7.3.6 Italy Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue by Type (2016-2026)
8.2 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue by Application (2016-2026)
8.3 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region
8.3.1 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue by Region (2016-2026)
8.3.2 China Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
8.3.3 Japan Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
8.3.4 South Korea Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
8.3.5 India Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
8.3.7 Australia Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Gene Therapy Medicinal Products (GTMP) Revenue by Type (2016-2026)
9.2 South America Gene Therapy Medicinal Products (GTMP) Revenue by Application (2016-2026)
9.3 South America Gene Therapy Medicinal Products (GTMP) Market Size by Country
9.3.1 South America Gene Therapy Medicinal Products (GTMP) Revenue by Country (2016-2026)
9.3.2 Brazil Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
9.3.3 Argentina Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Revenue by Type (2016-2026)
10.2 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Revenue by Application (2016-2026)
10.3 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country
10.3.1 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Revenue by Country (2016-2026)
10.3.2 Turkey Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
10.3.4 UAE Gene Therapy Medicinal Products (GTMP) Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Gene Therapy Medicinal Products (GTMP) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Gene Therapy Medicinal Products (GTMP) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Gene Therapy Medicinal Products (GTMP) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Gene Therapy Medicinal Products (GTMP) Revenue (USD Million) by Region (2016-2021)
Table 5. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Region (2021-2026)
Table 6. Bluebird Bio Corporate Information, Head Office, and Major Competitors
Table 7. Bluebird Bio Major Business
Table 8. Bluebird Bio Gene Therapy Medicinal Products (GTMP) Product and Solutions
Table 9. Bluebird Bio Gene Therapy Medicinal Products (GTMP) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Sangamo Corporate Information, Head Office, and Major Competitors
Table 11. Sangamo Major Business
Table 12. Sangamo Gene Therapy Medicinal Products (GTMP) Product and Solutions
Table 13. Sangamo Gene Therapy Medicinal Products (GTMP) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Spark Therapeutics Corporate Information, Head Office, and Major Competitors
Table 15. Spark Therapeutics Major Business
Table 16. Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Product and Solutions
Table 17. Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Dimension Therapeutics Corporate Information, Head Office, and Major Competitors
Table 19. Dimension Therapeutics Major Business
Table 20. Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Product and Solutions
Table 21. Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Avalanche Bio Corporate Information, Head Office, and Major Competitors
Table 23. Avalanche Bio Major Business
Table 24. Avalanche Bio Gene Therapy Medicinal Products (GTMP) Product and Solutions
Table 25. Avalanche Bio Gene Therapy Medicinal Products (GTMP) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Celladon Corporate Information, Head Office, and Major Competitors
Table 27. Celladon Major Business
Table 28. Celladon Gene Therapy Medicinal Products (GTMP) Product and Solutions
Table 29. Celladon Gene Therapy Medicinal Products (GTMP) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Vical Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Vical Inc. Major Business
Table 32. Vical Inc. Gene Therapy Medicinal Products (GTMP) Product and Solutions
Table 33. Vical Inc. Gene Therapy Medicinal Products (GTMP) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Advantagene Corporate Information, Head Office, and Major Competitors
Table 35. Advantagene Major Business
Table 36. Advantagene Gene Therapy Medicinal Products (GTMP) Product and Solutions
Table 37. Advantagene Gene Therapy Medicinal Products (GTMP) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Gene Therapy Medicinal Products (GTMP) Revenue (USD Million) by Players (2019-2021)
Table 39. Global Gene Therapy Medicinal Products (GTMP) Revenue Share by Players (2019-2021)
Table 40. Breakdown of Gene Therapy Medicinal Products (GTMP) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Gene Therapy Medicinal Products (GTMP) Players Head Office, Products and Services Provided
Table 42. Gene Therapy Medicinal Products (GTMP) Mergers & Acquisitions in the Past Five Years
Table 43. Gene Therapy Medicinal Products (GTMP) New Entrants and Expansion Plans
Table 44. Global Gene Therapy Medicinal Products (GTMP) Revenue (USD Million) by Type (2016-2021)
Table 45. Global Gene Therapy Medicinal Products (GTMP) Revenue Share by Type (2016-2021)
Table 46. Global Gene Therapy Medicinal Products (GTMP) Revenue Forecast by Type (2021-2026)
Table 47. Global Gene Therapy Medicinal Products (GTMP) Revenue by Application (2016-2021)
Table 48. Global Gene Therapy Medicinal Products (GTMP) Revenue Forecast by Application (2021-2026)
Table 49. North America Gene Therapy Medicinal Products (GTMP) Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Gene Therapy Medicinal Products (GTMP) Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Gene Therapy Medicinal Products (GTMP) Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Gene Therapy Medicinal Products (GTMP) Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Gene Therapy Medicinal Products (GTMP) Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Gene Therapy Medicinal Products (GTMP) Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Gene Therapy Medicinal Products (GTMP) Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Gene Therapy Medicinal Products (GTMP) Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Gene Therapy Medicinal Products (GTMP) Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Gene Therapy Medicinal Products (GTMP) Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Gene Therapy Medicinal Products (GTMP) Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Gene Therapy Medicinal Products (GTMP) Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Gene Therapy Medicinal Products (GTMP) Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Gene Therapy Medicinal Products (GTMP) Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Gene Therapy Medicinal Products (GTMP) Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Gene Therapy Medicinal Products (GTMP) Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Gene Therapy Medicinal Products (GTMP) Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Gene Therapy Medicinal Products (GTMP) Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Gene Therapy Medicinal Products (GTMP) Picture
Figure 2. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type in 2020
Figure 3. Oral
Figure 4. Injection
Figure 5. Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Application in 2020
Figure 6. Cancer Picture
Figure 7. Monogenic Picture
Figure 8. Infectious Disease Picture
Figure 9. Cardiovascular Disease Picture
Figure 10. Other Picture
Figure 11. Global Gene Therapy Medicinal Products (GTMP) Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Gene Therapy Medicinal Products (GTMP) Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Region (2016-2026)
Figure 14. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Region in 2020
Figure 15. North America Gene Therapy Medicinal Products (GTMP) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Gene Therapy Medicinal Products (GTMP) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Gene Therapy Medicinal Products (GTMP) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Gene Therapy Medicinal Products (GTMP) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Gene Therapy Medicinal Products (GTMP) Market Drivers
Figure 21. Gene Therapy Medicinal Products (GTMP) Market Restraints
Figure 22. Gene Therapy Medicinal Products (GTMP) Market Trends
Figure 23. Bluebird Bio Recent Developments and Future Plans
Figure 24. Sangamo Recent Developments and Future Plans
Figure 25. Spark Therapeutics Recent Developments and Future Plans
Figure 26. Dimension Therapeutics Recent Developments and Future Plans
Figure 27. Avalanche Bio Recent Developments and Future Plans
Figure 28. Celladon Recent Developments and Future Plans
Figure 29. Vical Inc. Recent Developments and Future Plans
Figure 30. Advantagene Recent Developments and Future Plans
Figure 31. Global Gene Therapy Medicinal Products (GTMP) Revenue Share by Players in 2020
Figure 32. Gene Therapy Medicinal Products (GTMP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Gene Therapy Medicinal Products (GTMP) Revenue Market Share in 2020
Figure 34. Global Top 10 Players Gene Therapy Medicinal Products (GTMP) Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Gene Therapy Medicinal Products (GTMP) Revenue Share by Type in 2020
Figure 37. Global Gene Therapy Medicinal Products (GTMP) Market Share Forecast by Type (2021-2026)
Figure 38. Global Gene Therapy Medicinal Products (GTMP) Revenue Share by Application in 2020
Figure 39. Global Gene Therapy Medicinal Products (GTMP) Market Share Forecast by Application (2021-2026)
Figure 40. North America Gene Therapy Medicinal Products (GTMP) Sales Market Share by Type (2016-2026)
Figure 41. North America Gene Therapy Medicinal Products (GTMP) Sales Market Share by Application (2016-2026)
Figure 42. North America Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Country (2016-2026)
Figure 43. United States Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Gene Therapy Medicinal Products (GTMP) Sales Market Share by Type (2016-2026)
Figure 47. Europe Gene Therapy Medicinal Products (GTMP) Sales Market Share by Application (2016-2026)
Figure 48. Europe Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Country (2016-2026)
Figure 49. Germany Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Region (2016-2026)
Figure 57. China Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Gene Therapy Medicinal Products (GTMP) Sales Market Share by Type (2016-2026)
Figure 64. South America Gene Therapy Medicinal Products (GTMP) Sales Market Share by Application (2016-2026)
Figure 65. South America Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Gene Therapy Medicinal Products (GTMP) Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Gene Therapy Medicinal Products (GTMP) Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Gene Therapy Medicinal Products (GTMP) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source

---